Neuromyelitis Optica - 57 Studies Found
Recruiting |
: Hematopoietic Stem Cell Transplant in Devic's Disease : Devic's Disease : 2008-10-31 : Procedure: Hematopoietic stem cell transplantation Mobiliz |
Recruiting |
: Efficacy and Safety Study as Monotherapy of SA237 to Treat NMO and NMOSD : Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD) : 2014-02-25 :
|
Recruiting |
: Efficacy and Safety Study as Add-on Therapy of SA237 to Treat NMO and NMOSD :
|
Enrolling by invitation |
: Mycophenolate Mofetil Treatment With Neuromyelitis Optica Spectrum Disorders in Chinese Patients :
|
Enrolling by invitation |
: Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders :
|
Completed |
: Phase II Clinical Trial of NPB-01 in Patients With Anti-aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorder Not Provided Adequate Effect of Therapy to Steroids Plus Therapy. : Neuromyelitis Optica Spectrum Disorder : 2013-04-26 : Drug: NPB-01 Other Name: Intravenous immunoglobulin |
Active, not recruiting |
: Efficacy and Safety of Bortezomib as add-on Treatment in Relapsing Neuromyelitis Optica Spectrum Disorder : Neuromyelitis Optica Spectrum Disorder : 2016-08-27 : Drug: Bortezomib Bortezomib will be subcutaneously applicated in 4 treatment cycles with 4 injections of |
Recruiting |
: A Double-masked, Placebo-controlled Study With Open Label Period to Evaluate MEDI-551 in Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders : Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders (NMO/NMOSD) : 2014-07-16 :
|
Active, not recruiting |
: Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses :
|
Active, not recruiting |
: Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders :
|